// App-Quantinova.ai

P062 : The narrow spectrum kinase inhibitor TOP1288 demonstrates potent anti-inflammatory effects in a T cell adoptive transfer colitis model through a topical mode of action

Researchers

Presenter

  • Y. Solanke

Principal Investigators

  • M. Foster

  • M. Fyfe

  • A. Rowley

  • S. Sirohi

  • S. Webber

  • C. Walshe

Medical Centers

  • Topivert Pharma, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved